Concepedia

Author

Howard West

City of HopeORCID

Also Known As

H L West, H West, H. J. West, H. Jack West, H. L. WEST, H. L. West, H. WEST, H. West, H.-. West, H.J. West

296

Publications

12.1K

Citations

42

H-Index

172

Concepts

All Affiliations

City of HopeUniversity of Colorado DenverFlorida Hospital Cancer InstituteMassachusetts General HospitalDana-Farber Cancer Institute
HW

About

Howard West is an author at City of Hope specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

65

6K

2

Health Sciences

12

13

499

3

Engineering

2

2

30

4

Arts

1

1

19

5

Education

1

1

27

Howard West

×

93

Publications

10.8K

Citations

38

H-Index

YearCitations

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Howard West, Michael McCleod, Maen Hussein,

The Lancet Oncology

2019

1.6K

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

Teresa Gómez‐Isla, Richard Hollister, Howard West,

Annals of Neurology

1997

1.5K

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study

Shirish M. Gadgeel, Leena Gandhi, Gregory J. Riely,

The Lancet Oncology

2014

688

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial

Alice T. Shaw, Leena Gandhi, Shirish M. Gadgeel,

The Lancet Oncology

2015

636

Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

Fred R. Hirsch, Marileila Varella‐Garcia, Jason McCoy,

Journal of Clinical Oncology

2005

584

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

Dong‐Wan Kim, Marcello Tiseo, Myung‐Ju Ahn,

Journal of Clinical Oncology

2017

577

Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial

Makoto Nishio, Fabrice Barlési, Howard West,

Journal of Thoracic Oncology

2020

430

Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease

Teresa Gómez‐Isla, Howard West, G. William Rebeck,

Annals of Neurology

1996

380

Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline

Natasha B. Leighl, Natasha Rekhtman, William A. Biermann,

Journal of Clinical Oncology

2014

288

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Fred R. Hirsch, Marileila Varella‐Garcia, Federico Cappuzzo,

Annals of Oncology

2007

270

Page 1